About Biotricity
Biotricity (NASDAQ:BTCY) specializes in delivering biometric monitoring solutions, focusing on healthcare with an innovative approach to remote monitoring for patients. This technology company is pioneering the development of advanced wearables and software, aiming to enhance patient care and outcomes across various medical conditions. Biotricity's projects revolve around creating reliable and accessible monitoring solutions, including their flagship heart monitoring devices tailored for individuals dealing with cardiovascular issues. The company's objective is to bridge the gap between healthcare professionals and patients, ensuring continuous care and monitoring outside traditional healthcare settings. By leveraging cutting-edge technology, Biotricity strives to improve the quality of life for patients, making healthcare more proactive, responsive, and personalized.
Snapshot
Operations
Products and/or services of Biotricity
- Bioflux is a real-time, high-precision mobile cardiac telemetry device designed for heart monitoring and diagnosis.
- Bioheart is a personal heart monitor for patients who require cardiac monitoring, offering continuous tracking and immediate feedback.
- Biotres is a 3-lead ECG monitoring device aimed at diagnosing and managing patients with arrhythmias and other cardiac conditions.
Biotricity executive team
- Dr. Waqaas Al-Siddiq Ph.D.Founder, President, CEO & Chairman
- Mr. S. John AyanoglouChief Financial Officer
- Amjad TalpurSenior Director of Operations
- Mr. Amir AliChief Development Officer
- Dr. Fareeha SiddiquiExecutive Vice President of Healthcare Solutions